Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies

Cardiovascular Pathology

Volumn 20, Issue 3, 2011, Pages 132-138

  Kucirka, Lauren M ^a   Maleszewski, Joseph J ^b   Segev, Dorry L ^a,c   Halushka, Marc K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cardiac transplantation; Humoral rejection; Pathology

Indexed keywords

CHLORDANE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE BIOPSY; HISTOPATHOLOGIC ANTIBODY MEDIATED REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MEDICAL PRACTICE; PATHOLOGIST; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; WORK EXPERIENCE;

ANTIBODIES; BIOPSY; COMPLEMENT ACTIVATION; DATA COLLECTION; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; NORTH AMERICA; OBSERVER VARIATION; PATHOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUALITY CONTROL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 79955691626     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2010.03.008     Document Type: Article

References (16)

1. Rodriguez ER, Skojec DV, Tan CD, Zachary AA, Kasper EK, Conte JV, Baldwin III WM. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005;5(11):2778-85.
2. Reed EF, Demetris AJ, Hammond E, Itescu S, Kobashigawa JA, Reinsmoen NL, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006;25(2):153-9. (Pubitemid 43156365)
3. Tan CD, Sokos GG, Pidwell DJ, Smedira NG, Gonzalez-Stawinski GV, Taylor DO, et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009;9:2075-84.
4. Rose AG. Understanding the pathogenesis and the pathology of hyperacute cardiac rejection. Cardiovasc Pathol 2002;11(3):171-6. (Pubitemid 34553417)
5. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24(11):1710-20.
6. Wasowska BA, Lee CY, Halushka MK, Baldwin 3rd WM. New concepts of complement in allorecognition and graft rejection. Cell Immunol 2007;248(1):18-30. (Pubitemid 350101456)
7. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004;4(7):1033-41. (Pubitemid 38868592)
8. Hammond ME, Stehlik J, Snow G, Renlund DG, Seaman J, Dabbas B, et al. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies. J Heart Lung Transplant 2005;24(12):2015-21. (Pubitemid 41814718)
9. Kfoury AG, Hammond ME, Snow GL, Stehlik J, Reid BB, Long JW, et al. Early screening for antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant 2007;26(12):1264-9. (Pubitemid 350256986)
10. Crespo-Leiro MG, Veiga-Barreiro A, Doménech N, Paniagua MJ, Piñón P, González-Cuesta M, et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 2005;5(10):2560-4.
11. Bonnaud EN, Lewis NP, Masek MA, Billingham ME. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 1995;14(1):163-71.
12. Gupta S, Mitchell JD, Lavingia B, Ewing GE, Feliciano MN, Kaiser PA, et al. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients. J Heart Lung Transplant 2009;28(8):776-80.
13. Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Hess ML, et al. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant 2006;25(12):1402-9. (Pubitemid 44909475)
14. Lones MA, Czer LS, Trento A, Harasty D, Miller JM, Fishbein MC. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 1995;14(1):151-62.
15. Kfoury AG, Hammond ME. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant 2010, doi:10.1016/j.healun.2009.10.016.
16. Wu G, Kobashigawa JA, Fishbein MC, Patel JK, Kittleson MM, Reed EF, et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009;28(5):417-22.